Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that ...

INDIANAPOLIS, March 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be ...

About Nuvectis Pharma, Inc. Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical ...

Multiple presentations demonstrate that T-knife’s proprietary next-generation technologies address important challenges with current cell therapy ...

Prezent, a startup developing a platform to create business side decks using AI, has raised a fresh $20 million in cash.

Held twice a month, the meeting begins with a closed session, where board members privately discuss matters such as student discipline, negotiations, and other topics. Once the discussion opened to ...

March 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five presentations related to ...

A professor of finance at the University of Kansas is a finalist to become the university’s next business school dean. Jide ...

AI has many different applications — one of which is generating decks for business presentations ... the company for which they’re creating a presentation. Users can also include team ...

Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a Phase 1 study of re-irradiation with JNJ-1900 (NBTXR3) for patients ...

Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner's New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema ...